Clinical Trial Update: Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA

View source ↗

Summary

This entry reports a completed ancillary clinical trial to the MESA study examining how serum sex hormone levels relate to subclinical atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease

Snippet

Sponsor: Northwestern University | Conditions: Cardiovascular Diseases, Atherosclerosis | Status: COMPLETED